Cornerstone Wealth Group LLC Increases Stock Holdings in Danaher Corporation (NYSE:DHR)

Cornerstone Wealth Group LLC raised its position in Danaher Corporation (NYSE:DHR) by 8.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 1,274 shares of the conglomerate’s stock after acquiring an additional 95 shares during the period. Cornerstone Wealth Group LLC’s holdings in Danaher were worth $261,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Fortis Capital Advisors LLC increased its position in shares of Danaher by 1.3% during the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock worth $914,000 after purchasing an additional 50 shares during the last quarter. Fayez Sarofim & Co boosted its stake in Danaher by 0.6% during the fourth quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate’s stock worth $1,902,000 after buying an additional 50 shares during the period. Coastal Bridge Advisors LLC increased its position in shares of Danaher by 4.8% during the fourth quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate’s stock valued at $252,000 after acquiring an additional 50 shares during the last quarter. Perennial Investment Advisors LLC raised its stake in shares of Danaher by 2.2% in the 4th quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate’s stock valued at $538,000 after acquiring an additional 51 shares during the period. Finally, Sound View Wealth Advisors Group LLC lifted its holdings in shares of Danaher by 3.1% in the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,739 shares of the conglomerate’s stock worth $399,000 after acquiring an additional 52 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock opened at $197.51 on Wednesday. The stock’s 50-day moving average is $194.11 and its two-hundred day moving average is $209.06. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70. The firm has a market cap of $141.35 billion, a price-to-earnings ratio of 38.35, a PEG ratio of 2.76 and a beta of 0.77.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher’s payout ratio is 24.85%.

Analysts Set New Price Targets

Several research analysts have recently commented on DHR shares. JPMorgan Chase & Co. lowered their price target on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Citigroup reissued a “buy” rating on shares of Danaher in a research report on Monday, April 7th. Wolfe Research cut their target price on shares of Danaher from $275.00 to $220.00 and set an “outperform” rating on the stock in a research note on Monday, April 7th. Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research note on Friday, March 14th. Finally, HSBC decreased their target price on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $248.61.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.20% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.